21-Gene recurrence score predictive for prognostic benefit of radiotherapy in patients age ≥ 70 with T1N0 ER/PR + HER2- breast cancer treated with breast conserving surgery and endocrine therapy
Neil Chevli, Waqar Haque, Kevin T. Tran, Andrew M. Farach, Mary R. Schwartz, Sandra S. Hatch, E. Brian Butler, Bin S. Teh
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of '21-Gene recurrence score predictive for prognostic benefit of radiotherapy in patients age ≥ 70 with T1N0 ER/PR + HER2- breast cancer treated with breast conserving surgery and endocrine therapy'. Together they form a unique fingerprint.